欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2011	Calcipotriol	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2007-223 - Rev 04	2025/07/11	Valid		Chemical	2025/10/31	Notification\|Accepted - CEP remains valid\|31/10/2025; Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|21/02/2023; Notification\|Accepted - CEP remains valid\|28/01/2022; Notification\|CEP granted\|04/01/2022; Minor revision\|CEP granted\|06/01/2021
2191	Atorvastatin calcium, Trihydrate Form-I, ATO3 Process	DR. REDDY'S LABORATORIES LIMITED Hyderabad IN	100003991;100000217	CEP 2025-113 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
2362	Rifaximin, α-Form	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2024-415 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
42	Magnesium carbonate, light	SCORA Caffiers FR	100017757;100026517	CEP 2024-058 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
549	Dexamethasone sodium phosphate	HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang CN	100016183;100024971	CEP 2023-448 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
2600	Olmesartan medoxomil	CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad IN	100053345;100094249	CEP 2018-232 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Renewal\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|20/09/2022; Major revision\|CEP granted\|08/07/2021; Minor revision\|Rejected\|22/02/2021
2071	Milk thistle dry extract, refined and standardised, DER: 20-35:1	NINGBO GREEN-HEALTH PHARMACEUTICAL CO. LTD. Ningbo CN	100021397;100030235	CEP 2012-275 - Rev 02	2025/07/11	Valid		Herbal	2025/07/11	Major revision\|CEP granted\|11/07/2025; Minor revision\|Rejected\|07/03/2025; Minor revision\|Accepted - CEP remains valid\|18/02/2025; Monograph revision\|CEP granted\|19/06/2024
2763	Cisatracurium besilate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2016-093 - Rev 01	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|04/07/2024; Notification\|Accepted - CEP remains valid\|13/04/2023; Renewal\|CEP granted\|16/05/2022; Notification\|CEP granted\|20/12/2021; Minor revision\|CEP granted\|29/05/2020
2631	Rosuvastatin calcium, Process G 2410	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2017-018 - Rev 01	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Renewal\|CEP granted\|20/05/2022; Notification\|CEP granted\|22/11/2021; Minor revision\|CEP granted\|09/07/2021; Monograph revision\|Accepted - CEP remains valid\|02/10/2020
412	Sodium citrate dihydrate	JUNGBUNZLAUER LADENBURG GMBH Ladenburg DE	100014785;100073136	CEP 2018-273 - Rev 06	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Renewal\|CEP granted\|21/10/2024; Notification\|CEP granted\|21/06/2024; Notification\|Accepted - CEP remains valid\|24/08/2023; Minor revision\|CEP granted\|01/09/2022; Minor revision\|CEP granted\|09/06/2021; Minor revision\|CEP granted\|04/06/2020
1520	Foscarnet sodium hexahydrate	LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Lianyungang CN	100019457;100028232	CEP 2017-137 - Rev 01	2025/07/11	Valid		Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025; Notification\|Accepted - CEP remains valid\|24/06/2024; Renewal\|CEP granted\|27/07/2023; Minor revision\|Accepted - CEP remains valid\|08/03/2022; Notification\|Accepted - CEP remains valid\|11/01/2022; Minor revision\|Accepted - CEP remains valid\|23/11/2020
2931	Sorafenib tosilate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2021-247 - Rev 02	2025/07/11	Valid	10/07/2028	Chemical	2025/07/11	Monograph revision\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|23/04/2024; New application\|CEP granted\|10/07/2023
883	Calcitriol, Process 2 (F007V1)	FORMOSA LABORATORIES, INC. Taoyuan TW	100011879;100018688	CEP 2020-150 - Rev 03	2025/07/11	Valid	22/10/2026	Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Monograph revision\|CEP granted\|18/12/2024; Administrative procedure\|CEP granted\|18/11/2021; New application\|CEP granted\|22/10/2021
1472	Sodium hyaluronate, GS-200; intrinsic viscosity 2.77 m3/kg; from fermentation; for parenteral administration, including intra-ocular use	KIKKOMAN BIOCHEMIFA CO. Noda City JP	100039417;100087689	CEP 2020-138 - Rev 01	2025/07/11	Valid		Chemical	2025/07/11	Renewal\|CEP granted\|11/07/2025; Notification\|Accepted - CEP remains valid\|03/05/2024; New application\|CEP granted\|28/08/2020
72	Cholecalciferol, Site Sisseln	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2019-351 - Rev 02	2025/07/11	Valid		Chemical and TSE	2025/11/26	Notification\|Accepted - CEP remains valid\|26/11/2025; Notification\|CEP granted\|11/07/2025; Renewal\|CEP granted\|14/03/2025
2777	Pregabalin	DR. REDDY'S LABORATORIES LIMITED Hyderabad IN	100003991;100000217	CEP 2020-024 - Rev 03	2025/07/11	Valid	03/02/2027	Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|19/06/2024; Major revision\|CEP granted\|16/09/2022; New application\|CEP granted\|03/02/2022
2631	Rosuvastatin calcium	CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL	100002351;100005259	CEP 2015-090 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|21/12/2023; Minor revision\|Accepted - CEP remains valid\|02/05/2023; Minor revision\|CEP granted\|20/04/2022; Minor revision\|Rejected\|02/03/2022; Renewal\|CEP granted\|01/07/2021; Monograph revision\|Accepted - CEP remains valid\|27/05/2020
2759	Benzydamine hydrochloride	BAL PHARMA LIMITED Bengaluru IN	100016398;100041736	CEP 2021-325 - Rev 02	2025/07/11	Valid	12/04/2029	Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025; Administrative procedure\|CEP granted\|05/06/2024; New application\|CEP granted\|12/04/2024
2594	Duloxetine hydrochloride, Process-K	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2024-273 - Rev 01	2025/07/11	Valid	22/10/2029	Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025; New application\|CEP granted\|22/10/2024
2288	Citalopram hydrobromide	CIPLA LIMITED Mumbai IN	100006004;100018147	CEP 2009-012 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Minor revision\|CEP granted\|11/07/2025

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-